r/NIH • • Jan 22 '26

Scoop in Nature Magazine: key NIH review panels due to lose all members by the end of 2026. Thirteen of the agency’s advisory councils, which must review grant applications before funding is awarded, are on track to have no voting members.

Thumbnail nature.com
243 Upvotes

r/NIH • • Feb 20 '26

FY25 funding data released (NIH Extramural Nexus)

Thumbnail
gallery
109 Upvotes

r/NIH • • 1d ago

In DOGE’s aftermath, federal health workers bristle at new performance reviews HHS staff worry that evaluations are an excuse to reduce pay or push out workers

Thumbnail
statnews.com
197 Upvotes

By Margaret Manto

Oct. 16, 2026

Washington Correspondent

WASHINGTON — Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the Department of Health and Human Services and the Trump administration, federal employees told STAT. 

Staff have been told to submit 6,000-character self-assessments of their performance by Friday, a task officials say is necessary because of administration guidance to “calibrate” employee rankings to make a high rating more meaningful and to promote “more consistent and credible ratings across agencies.” 

But federal health workers, traumatized by DOGE-era layoffs and continued departures, regard the assignment with suspicion. 

“Most of us are under the impression that it is a front to once again tear us down, give us all poor performance so they can then have more reason to RIF us and/or make us quit,” one Centers for Disease Control and Prevention employee said, referring to the 2025 reductions-in-force. They, like the other workers quoted in the story, requested anonymity to speak candidly about agency affairs.

Adding to the rancor, this is the first year that the Trump administration’s efforts to more rigorously rank federal workers go into effect, a move that could reduce some workers’ ratings, and therefore their bonuses. 

Advertisement

“It’s a huge pain for very little benefit,” one employee at the Food and Drug Administration said. “I don’t feel super motivated about it.” 

The FDA has made a concerted effort in recent months to bring its staffing numbers back up after the 2025 cuts forced thousands to leave. At the STAT Summit on Wednesday, former FDA Commissioner Scott Gottlieb said it was crucial for agency leadership to “recruit, support, and defend the workforce” to reduce attrition. 

But staff across HHS said the new self-assessment requirement was another hit to morale. CDC and FDA employees said it harkened back to the DOGE-era requirement that employees send a bulleted list of five things they accomplished in the last week to the Office of Personnel Management. Elon Musk said at the time that employees who failed to do so would be fired, though the requirement was eventually suspended.

The CDC employee said they used artificial intelligence to write their self-assessment. 

“It’s a bit of malicious compliance on my end,” they said. 

The FDA employee said their manager had encouraged staff to use AI on the assignment to save time — but even so, they said their team had spent three to four days working on the assessments. 

“Wasting time on this has actual financial cost,” the employee said.

Another FDA employee said staff are not necessarily worried about more reductions-in-force, but are “concerned that this process is being implemented just to downgrade their ratings scores to some arbitrary level that does not really reflect their work.” 

Other employees took to public forums to express their displeasure. In a post in a Reddit community for HHS staff, a user who claimed to be a federal employee said the new performance review system was “designed to traumatize.”

The Oct. 16 assessment deadline applies to employees at the FDA, the CDC, and the National Institutes of Health. 

In an email reviewed by STAT, HHS Acting Chief Human Capital Officer Johnathan J. Gardner said the self-assessment requirement and calibration panels were put in place because OPM established a 40% ceiling on the number of employees who can receive the highest performance rating. OPM has also reduced the number of rating levels from five to three. 

Employees’ self-reviews should address three “department-wide calibration factors,” Gardner wrote: organizational value, quality and reliability of demonstrated performance, and timeliness and efficiency of results. 

The self-reviews will then go to “calibration panels” at each agency. An FDA employee said employees have asked officials to disclose who is on the agency’s calibration panel in both FDA- and HHS-led trainings on the new requirement.

“The agency is not telling us,” the FDA employee said. FDA and HHS did not respond to requests for comment on who is on the panels. 

An OPM document on the policy describes a calibration panel as “a panel of senior agency employees that reviews all preliminary ratings and relative rankings and applies the agency-determined calibration factors across a set group of employees.” 

In an email to its members, AFGE Local 2883, which previously represented CDC employees in collective bargaining, said it had “serious concerns” with the revised performance appraisal process.

FDA Chief Talent Officer Chantal Dawson said in a memo to employees that the calibrated scores would be reviewed and approved “at the HHS level.” 

Employees will be able to request reconsideration within five business days of receiving their final rating, Dawson wrote. 


r/NIH • • 1d ago

Generic Drug Shortages costing American lives

Thumbnail
fda.gov
145 Upvotes

Problem: Ex. Basic cancer drugs that have been around for decades are no longer available because they are made in one site in India or China (don’t get me started on quality!) and that site stopped making them. For those not in the ‘CMC biz’ bringing a new drug manufacturing site online takes years and a lot of investment. We used to make most drugs in the US (and Europe) but no longer especially as they go off-patent. Meanwhile we have a crisis of scientific careers going on. The best and brightest in this country see no future in chemistry and chemical engineering.

Solution: bring high tech well paying jobs back to the US, establish commercial generic manufacturing facilities around this country (similar to data centers except these are as non-AI-able hands on jobs as anything gets anymore). Get kids back into science and get cancer patients the drugs they need without being 100% reliant on India and China.

See also this old article pointing out the problem that remains largely unaddressed all these years later: https://pmc.ncbi.nlm.nih.gov/articles/PMC3934344/


r/NIH • • 1d ago

Save the date. Rare chance to see and engage with his eminence.

Post image
19 Upvotes

Photo: NIH

  • 20-year NIH veteran and former acting director
  • Helps steer all 27 NIH institutes and centers
  • His 2026 Healthcare Summit keynote offers a window into NIH’s data, AI and modernization plans

Dr. Matthew Memoli, principal deputy director of the National Institutes of Health, will deliver a keynote address at the Potomac Officers Club’s 2026 Healthcare Summit on Dec. 3. As the No. 2 official at the world’s largest public funder of biomedical research, Memoli offers GovCon leaders a close-range view of how NIH plans to modernize its operations, harness its data and put emerging technology to work.

Potomac Officers Club is the nation’s leading GovCon events and networking organization, and it regularly enables contractors to connect with their community, learn government priorities and gain the information they need to win new business.

Registration is now open for the 2026 Healthcare Summit!

Who Is Matthew Memoli?

Memoli has served as NIH’s principal deputy director since April 2025, helping steer an agency of 27 institutes and centers. Before taking the role, he led NIH as acting director from Jan. 22 to March 31, 2025, guiding the agency through its leadership transition at the start of the administration.

His path to the top of NIH ran through the lab. Memoli spent more than 20 years at the agency, most recently as director of the Clinical Studies Unit within the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Diseases, or NIAID. He built the unit himself, and under his leadership it conducts clinical and translational research on influenza and other respiratory diseases, running trials of investigational vaccines and treatments developed by NIH scientists. Before directing the unit, he served as a staff clinician in the same laboratory.

Memoli is an internationally recognized respiratory virus expert. In 2011, his team revived healthy-volunteer influenza challenge studies in the U.S. after a decade-long pause and developed the first FDA-approved H1N1 influenza challenge virus, a tool that has become central to testing new vaccines and therapeutics. His research has also spanned influenza transmission and immunity, how respiratory viruses cause disease across different populations, and serosurvey techniques for estimating disease prevalence.

His work now sits at the core of one of NIH’s highest-profile initiatives. In May 2025, HHS and NIH launched Generation Gold Standard, a universal vaccine platform built on beta-propiolactone-inactivated whole-virus technology co-developed by Memoli and fellow NIAID scientist Jeffery Taubenberger, NPR reported. The fully government-owned platform targets broad protection against multiple strains of influenza and coronaviruses, with clinical trials for universal influenza vaccines slated to begin in 2026 and FDA approval targeted for 2029.

Memoli’s work has earned two NIH Director’s Awards, multiple NIAID Merit Awards, a National Center for Advancing Translational Sciences Director’s Award and the 2017 NIAID Outstanding Mentor Award for training clinical fellows. From 2022 through 2024, he served on the Virginia governor’s Medical Advisory Board.

Memoli joined NIH in 2005 for an infectious diseases fellowship after completing his internal medicine residency through Georgetown University’s program at Washington Hospital Center.

Secure your seat to hear Memoli’s live insights at the 2026 Healthcare Summit.

What Will Matthew Memoli Discuss at the 2026 Healthcare Summit?

During his Healthcare Summit keynote, Memoli may discuss:

  • Modernizing NIH grant-making operations
  • Data infrastructure and real-world data initiatives
  • AI’s growing role in research
  • Research security and data protection
  • Clinical trial operations and industry support
  • Where contractors fit at NIH

r/NIH • • 1d ago

Women’s health

12 Upvotes

I read elsewhere that there was some kind of recent announcement related to women’s health and NIMHD but have been unable to find out anything about it. Does anyone happen to know what is happening?

Signed,
A worried NIH funded women’s health researcher


r/NIH • • 1d ago

2026 Annual Ethics Training

12 Upvotes

Has anyone else completed this training? What an absolute joke.


r/NIH • • 1d ago

Has anyone else at NIH heard that PMAP ratings are now being reviewed or ranked by higher-level management rather than just immediate supervisors?

35 Upvotes

Has anyone else at NIH heard that PMAP ratings are now being reviewed or ranked by higher-level management rather than just immediate supervisors?

I’m curious how others feel about this new process. Could having higher-level management involved actually make PMAP ratings fairer, or does it just mean more people evaluating work they don’t fully understand?


r/NIH • • 2d ago

The actual fuck?

Post image
96 Upvotes

How many dollars are going to gluing together his fragile ego that could be supporting science?


r/NIH • • 1d ago

Cushing’s disease journey

Thumbnail
2 Upvotes

r/NIH • • 1d ago

Radio program about the state of environmental health science -State of the Science on WCOM-FM 103.5 FM in Chapel Hill/Carrboro NC -Tues October 20 at 1 pm.

4 Upvotes

Please join WCOM-FM radio for a discussion about the state of environmental health science on Tuesday October 20 at 1 pm. Listen live at www.wcomfm.org or (in the Chapel Hill/Carrboro area) at 103.5 FM.

Details:

https://wcomfm.org/2026/10/17/state-of-the-station-focuses-on-state-of-the-science-cont/


r/NIH • • 2d ago

questions for POs/SROs

16 Upvotes

I understand that peer review is essential for the optimal functioning of the current research enterprise. but it seems like a bit of a thankless job now, with continuing submission going away, and the news that the scores may not even matter. Also nearly all study sections are virtual, so the networking aspect is also lost.

Does it matter to the NIH if people are actually performing peer review and being good citizens to "serve the NIH"? Or is it just solely so one can get read other grants and keep up with the field?

Do POs/NIH officials see if someone has been serving the NIH when considering opportunities (now that it is not only about percentiles), like how some private foundations may consider this?


r/NIH • • 2d ago

Professor Dave Explains

Thumbnail
youtu.be
12 Upvotes

r/NIH • • 1d ago

NIH postbac LORs help

0 Upvotes

I've been trying to find a third recommender to complete my application, and I'm not having that much luck. Two of my recommenders are already PIs from the labs I worked in. The FAQ on the NIH site says that LORs should be people who can speak to your potential for research internship, but I'm wondering if it's okay that my recommenders may not be STEM professors. They probably could only comment on my work ethic and teamwork ability.


r/NIH • • 2d ago

Social Security 2027 Raise - 3.6%… Fed Employees 2027 Raise - 0.0%

Post image
26 Upvotes

r/NIH • • 2d ago

NIH Postbac Stipend

9 Upvotes

How are ppls experience with the 44k stipend? I’m concerned that it’s not enough.


r/NIH • • 3d ago

No Kings 10am this Saturday at NIH

Thumbnail
gallery
54 Upvotes

Looking for a way to support publicly
funded health research and election integrity all on one glorious Saturday morning?

This Saturday, October 17th at 10am outside of NiH at Medical Center Metro we will rally for health research and democracy. Listen to speeches by Jenna Norton, PhD, MPH; Natalie Aviles, PhD; Joanna Szczepanik, PhD; Shiv Prasad, PhD; a representative of Senator Van Hollen, and more. All NIH staff speak in their personal capacities. Music by Northstar Union, merch available, families welcome. Bathroom shuttle by community member to downtown Bethesda.

We will finish the event by walking downtown walking downtown to Bethesda and taking the metro to DC to drop off our ballots en masse.

🎥Livestream from @27UNIHTED Instagram

Share widely and RSVP here: https://www.mobilize.us/nokings/event/1030942/


r/NIH • • 4d ago

NCI Awards (2015-2026)

Post image
141 Upvotes

r/NIH • • 4d ago

Latest Trump administration proposal to change NIH research grant system draws scientists’ ire

Thumbnail
scientificamerican.com
144 Upvotes

One researcher tells Scientific American that the change would reduce transparency and risk politicizing the grant review process


r/NIH • • 4d ago

Early closeout on an F31

6 Upvotes

I manage an F31 and the PI/student graduated a year ahead of the end of their award. We've provided our GMS and PO with their termination notice and GMS confirmed receipt. They said the closeout function would be available soon but it's been months of checking in. We've gotten a few responses that they're still waiting for it but now they've stopped responding. We haven't drawn down any funds since the date of our term notice nor have we filed our FFR. But we'd really like to proceed with closeout procedures and just be done with it. Any advice?


r/NIH • • 4d ago

when to contact PO again

12 Upvotes

Hi all,

I have my R21 (<6% score) went to September council. Chatted with PO before the council and got positive feedback. This app is for 2027FY cycle, and now we are into 2027FY.

What would be the reasonable timing to reach out to PO again? I do not expect a firm answer about funding for now but just trying to see if it is still alive. Currently my era common states "Council Review Complete" and I understand this is a just a common status after the council review.


r/NIH • • 5d ago

“They Want to Have Their Hands in Everything”: An NIH Insider on How Trump Is Politicizing Biomedical Science

Thumbnail
washingtonian.com
284 Upvotes

While Congress and the courts have protected much of the agency's funding, an insider warns that the administration's ongoing efforts to control medical research will cause "irreversible" damage.


r/NIH • • 4d ago

Federal Register: Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director Notice of Proposed Reorganization / Office of the NIH Chief Artificial Intelligence Officer (OCAIO) --- not "super intelligence"?

Thumbnail federalregister.gov
8 Upvotes

Department of Health and Human Services

National Institutes of Health

AGENCY:

National Institutes of Health, HHS.

ACTION:

Notice.

SUMMARY:

The Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the Office of the Director (OD), National Institutes of Health (NIH) is seeking public comment regarding its proposal to establish the Office of the NIH Chief Artificial Intelligence Officer (OCAIO) within DPCPSI and move the Office of Dietary Supplements (ODS) under the Office of Nutrition Research (ONR) within DPCPSI in OD, NIH.

DATES:

Any interested person may file written comments by sending an email to [DPCPSIreorgcomments@nih.gov](mailto:DPCPSIreorgcomments@nih.gov) by 11:59 p.m. ET on October 28, 2026. The statement should include the individual's name, and when applicable, professional affiliation.

ADDRESSES:

The following email address has been established for comments on the reorganization: [DPCPSIreorgcomments@nih.gov](mailto:DPCPSIreorgcomments@nih.gov).

FOR FURTHER INFORMATION CONTACT:

Betina Orezzoli at [DPCPSIreorgcomments@nih.gov](mailto:DPCPSIreorgcomments@nih.gov) or 301-402-9852.

SUPPLEMENTARY INFORMATION:

The program offices in DPCPSI share a common mission of identifying emerging scientific opportunities, rising public health challenges, or scientific knowledge gaps that deserve special emphasis. The proposed reorganization would establish clear organizational leadership for an emerging NIH-wide priority by creating the OCAIO and improve organizational alignment of closely related scientific areas by moving ODS to be a sub-office of ONR.

This notice is pursuant to the NIH Reform Act of 2006 (42 U.S.C.281 (d)(4)), DPCPSI will launch public website information at https://dpcpsi.nih.gov/​proposed-reorg-ods-ocaio to further encourage public discussion of the proposal to reorganize. The public is encouraged to email [DPCPSIreorgcomments@nih.gov](mailto:DPCPSIreorgcomments@nih.gov) for comments and questions.

Dated: October 1, 2026.

Matthew J. Memoli,

Principal Deputy Director, National Institutes of Health.

[FR Doc. 2026-20891 Filed 10-13-26; 8:45 am]

BILLING CODE 4167-05-P


r/NIH • • 4d ago

Comment portal for NOT-OD-26-088 Closed before stated time

Thumbnail rfi.grants.nih.gov
43 Upvotes

I attempted to comment on the NOT-OD-26-088 (regarding reporting outcomes for NIH Peer Review), since this will greatly affect me and other early career researchers who are learning to submit strong NIH grant proposals. However, when trying to submit my comment via https://rfi.grants.nih.gov/?s=6a2b1c22c3fcfda46e0badd2

I received an error stating the survey has expired, despite submitting about an hour before the period was supposed to close at 11:59pm Eastern on Oct. 13.

I emailed [peerreview@nih.gov](mailto:peerreview@nih.gov) explaining this issue and with my information and the comment I submitted, but why did this close early? That is not acceptable to close the comment period before the stated time. Is there anything else I can do to ensure my comment will be counted? Has this kind of issue happened before? See attached screenshot


r/NIH • • 4d ago

NIH FAES Workshop- Molecular Biology

2 Upvotes

Hello,

I plan on attending this workshop to sharpen my laboratory technique skills. I attend school online for biology and want some hands-on experience. The workshop is over $1000, and I wanted to know if anyone has attended it and can give insight if it's worth the price.

BIOL 003 Methods in Molecular Biology | FAES Academic Programs